A recent study has found that severe cases COVID-19 or influenza can leave lasting changes in the lungs that increase the risk of lung cancer years later. The study was conducted by researchers from ...
Immutep Limited IMMP shares are tumbling on Friday following the company’s update for the TACTI-004 Phase 3 trial. The Australia-based biotech announced that the Independent Data Monitoring Committee ...
AAP Newsroom on MSN
Biotech shares plunge after lung cancer drug's failure
An ASX biotech formerly worth over $500 million has lost most of its value after its drug failed to treat lung cancer ...
A newly released publication examines how deuterium concentration may influence gene activity in lung cancer cells. The study explores how shifts in this ...
Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study that paves the way ...
Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne ...
The MarketWatch News Department was not involved in the creation of this content. Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising ...
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...
Somatic pathogenic genomic alterations in patients with SCBC, UC, and SCLC of any stage who underwent blood- or tissue-based genomic profiling through the Tempus assay were cataloged. Baseline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results